Key Takeaways
- MOTS-c is not FDA-approved and is available for research purposes only.
- Typical dosing protocols are derived from preclinical studies and are not standardized across clinical settings.
- Titration schedules are crucial for optimizing tolerability and efficacy.
- Administration is typically via subcutaneous injection, with specific guidelines for injection sites and storage.
- Medical supervision is essential due to the experimental nature of MOTS-c.
What Is MOTS-c?
MOTS-c is a mitochondrial-derived peptide composed of 16 amino acids, encoded by the 12S rRNA region of the mitochondrial genome. It plays a role in cellular metabolism and is currently under investigation for its potential therapeutic applications in metabolic disorders. For a comprehensive overview, visit the MOTS-c full profile.
Standard Dosing Protocols
MOTS-c is not FDA-approved and is available only for research purposes. Consequently, there are no standardized dosing protocols sanctioned by regulatory bodies. Research studies, such as those documented in PMID 36761202 and PMID 34798268, have explored various dosing regimens in preclinical settings. Typical dosing in these studies ranges from 1 mg/kg to 5 mg/kg, administered via subcutaneous injection, but these should not be considered prescriptive for clinical use.
Titration Schedules
In research settings, titration schedules are employed to gradually increase the dose of MOTS-c, allowing researchers to assess tolerability and efficacy. This gradual escalation helps to identify the optimal therapeutic window and minimize potential side effects. For example, a study might start at a lower dose of 1 mg/kg and increase incrementally over several weeks to a target dose of 5 mg/kg, as observed in various preclinical trials.
Administration Method
MOTS-c is typically administered via subcutaneous injection. This involves injecting the peptide into the fatty tissue beneath the skin, often in areas like the abdomen or thigh. A fine needle, usually 27 to 30 gauge, is recommended for comfort and efficacy. Proper storage is critical; reconstituted MOTS-c should be kept refrigerated and used within a specified time frame to maintain stability and potency.
Factors That Affect Dosing
Dosing of MOTS-c can be influenced by several factors, including body weight, treatment goals, and the presence of other medical conditions. For instance, individuals with impaired kidney or liver function may require adjusted dosing to prevent potential toxicity. A healthcare provider will consider these variables to tailor the dosing regimen to the patient's specific needs.
What Happens If You Miss a Dose
In a research context, missing a dose of MOTS-c should be addressed by consulting the study protocol or a supervising researcher. Generally, the missed dose should be administered as soon as possible unless it is close to the time of the next scheduled dose, in which case the missed dose should be skipped to avoid doubling up.
Dosing Compared to Similar Peptides
Compared to other mitochondrial-derived peptides, such as humanin, which also targets cellular metabolism, MOTS-c dosing is less standardized due to its research-only status. Humanin, for instance, has more established dosing guidelines in preclinical studies, often involving similar administration routes and titration strategies.
What the Evidence Does Not Show
While preclinical studies suggest potential benefits of MOTS-c in metabolic regulation and disease mitigation, long-term safety and efficacy in humans remain unproven. Current research is limited to animal models and in vitro studies, and more robust clinical trials are needed to establish definitive dosing guidelines and therapeutic outcomes.
FAQ
How is MOTS-c typically administered?
MOTS-c is usually given via subcutaneous injection, often in the abdomen or thigh.
Is MOTS-c FDA-approved?
No, MOTS-c is not FDA-approved and is available for research purposes only.
What should I do if I miss a dose of MOTS-c?
Consult the research protocol or supervising researcher. Generally, administer the missed dose as soon as possible unless the next dose is imminent.
Can MOTS-c dosing be adjusted for individual needs?
Yes, factors like body weight and other medical conditions can influence dosing adjustments.
How does MOTS-c compare to other peptides?
MOTS-c is similar to other mitochondrial-derived peptides like humanin in its metabolic effects but lacks standardized dosing due to its research status.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.
Find a Peptide Therapy Clinic Near You
Browse our directory of verified peptide therapy clinics across the United States. Compare providers, read reviews, and request a consultation.
PeptideClinicLocator.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.



